Shannon Michelle Kidd, SLP | |
93 Link Dr, Pine Knot, KY 42635-9155 | |
(606) 310-9795 | |
(606) 354-3537 |
Full Name | Shannon Michelle Kidd |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 93 Link Dr, Pine Knot, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356439806 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | KY-2595 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shannon Michelle Kidd, SLP 93 Link Dr, Pine Knot, KY 42635-9155 Ph: (606) 310-9795 | Shannon Michelle Kidd, SLP 93 Link Dr, Pine Knot, KY 42635-9155 Ph: (606) 310-9795 |
News Archive
Scientists in Australia have found a way of identifying probable stem cells in the lining of women's wombs. The finding opens up the possibility of using the stem cells for tissue engineering applications such as building up natural tissue to repair prolapsed pelvic floors.
A study led by Indiana University suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications.
The Global Democracy Promotion Act, recently introduced in the House by Rep. Nita Lowey, "would bar the use of U.S. foreign aid to restrict people's liberty and says that organizations accepting U.S. assistance cannot be forced to quash perfectly legal activities in return," Planned Parenthood Federation of America Vice President Latanya Mapp Frett writes in a New York Daily News opinion piece.
A multi-institutional, international team of scientists has discovered the genetic cause and biological mechanisms linked to a new human immunodeficiency. The study, which is published in Nature Immunology, also identifies a potential treatment.
A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease.
› Verified 6 days ago